Industry Strength Score
55/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
FINANCIERE DE TUBIZE (TUB.BR) Stock Price & Overview
EBR:TUB • BE0003823409
Current stock price
195.7 EUR
+4.2 (+2.19%)
Last:
The current stock price of TUB.BR is 195.7 EUR. Today TUB.BR is up by 2.19%. In the past month the price decreased by -7.69%. In the past year, price increased by 47.36%.
TUB.BR Key Statistics
52-Week Range114.8 - 250.5
Current TUB.BR stock price positioned within its 52-week range.
1-Month Range189.2 - 230.4
Current TUB.BR stock price positioned within its 1-month range.
- Market Cap
- 8.711B
- P/E
- 93.64
- Fwd P/E
- N/A
- EPS (TTM)
- 2.09
- Dividend Yield
- 0.35%
TUB.BR Stock Performance
Today
+2.19%
1 Week
-6.99%
1 Month
-7.69%
3 Months
-8.76%
Longer-term
6 Months -7.47%
1 Year +47.36%
2 Years +101.34%
3 Years +154.82%
5 Years +139.83%
10 Years +254.21%
TUB.BR Stock Chart
TUB.BR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to TUB.BR. When comparing the yearly performance of all stocks, TUB.BR is one of the better performing stocks in the market, outperforming 79.57% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
TUB.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TUB.BR. The financial health of TUB.BR is average, but there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TUB.BR Earnings
Next Earnings DateJul 31, 2026
Last Earnings DateMar 21, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
TUB.BR Forecast & Estimates
6 analysts have analysed TUB.BR and the average price target is 256.53 EUR. This implies a price increase of 31.08% is expected in the next year compared to the current price of 195.7.
Analysts
Analysts76.67
Price Target256.53 (31.08%)
EPS Next YN/A
Revenue Next YearN/A
TUB.BR Index Membership
TUB.BR is currently included in the following stock indexes tracked on ChartMill.
TUB.BR Financial Highlights
Over the last trailing twelve months TUB.BR reported a non-GAAP Earnings per Share(EPS) of 2.09. The EPS increased by 3.47% compared to the year before.
Income Statements
Revenue(TTM)N/A
Net Income(TTM)93.23M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 4.82% | ||
| ROE | 4.94% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%17.27%
Sales Q2Q%N/A
EPS 1Y (TTM)3.47%
Revenue 1Y (TTM)N/A
TUB.BR Ownership
Ownership
Inst Owners7.06%
Shares44.51M
Float20.70M
Ins Owners33.27%
Short Float %N/A
Short RatioN/A
TUB.BR Industry Overview
TUB.BR operates in the Pharmaceuticals sub-industry within the Health Care sector. This group contains 26 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
59/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
26%
Outperformed 26% of sub-industries
3 Month Rank
28%
Outperformed 28% of sub-industries
6 Month Rank
49%
Outperformed 49% of sub-industries
Industry Fundamentals & Breadth
- Members
- 26
- New Highs
- 0%
- New Lows
- 3.9%
- Average ROE
- 15.4%
- Average Profit Margin
- 17.1%
- Average Operating Margin
- 23%
- Average P/E
- 14.7
- Average Fwd P/E
- 11.8
- Average Debt/Equity
- 0.4
TUB.BR Competitors/Peers
The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SAN | SANOFI | 8.79 | 96.756B | ||
| SNW | SANOFI | 8.79 | 96.756B | ||
| 1SAN | SANOFI | 8.6 | 94.671B | ||
| MRK | MERCK KGAA | 13.95 | 47.848B | ||
| UCB | UCB SA | 21.9 | 44.971B | ||
| UNC | UCB SA | 21.24 | 43.629B | ||
| 1BAYN | BAYER AG-REG | 8.66 | 37.43B | ||
| BAYN | BAYER AG-REG | 8.65 | 37.381B | ||
| IPN | IPSEN | 13.19 | 13.996B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.7 | 10.381B | ||
| VIRP | VIRBAC SA | 17.37 | 3.117B | ||
| DMP | DERMAPHARM HOLDING SE | 18.78 | 2.495B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About TUB.BR
Company Profile
Financiere de Tubize SA is a holding company, which engages in investing in the biopharmaceuticals industry. The company is headquartered in Brussels, Bruxelles-Capitale. The firm holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The firm promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.
Company Info
IPO: 1987-01-02
FINANCIERE DE TUBIZE
Allee de la Recherche, 60
Brussels BRUXELLES-CAPITALE BE
Employees: 3
Phone: 320497515208
FINANCIERE DE TUBIZE / TUB.BR FAQ
What does TUB do?
Financiere de Tubize SA is a holding company, which engages in investing in the biopharmaceuticals industry. The company is headquartered in Brussels, Bruxelles-Capitale. The firm holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The firm promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.
What is the stock price of FINANCIERE DE TUBIZE today?
The current stock price of TUB.BR is 195.7 EUR. The price increased by 2.19% in the last trading session.
What is the dividend status of FINANCIERE DE TUBIZE?
FINANCIERE DE TUBIZE (TUB.BR) has a dividend yield of 0.35%. The yearly dividend amount is currently 1.04.
What is the ChartMill rating of FINANCIERE DE TUBIZE stock?
TUB.BR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is FINANCIERE DE TUBIZE (TUB.BR) stock traded?
TUB.BR stock is listed on the Euronext Brussels exchange.
What is the market capitalization of TUB stock?
FINANCIERE DE TUBIZE (TUB.BR) has a market capitalization of 8.71B EUR. This makes TUB.BR a Mid Cap stock.
What is the next earnings date for TUB stock?
FINANCIERE DE TUBIZE (TUB.BR) will report earnings on 2026-07-31.